Webinar – Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips
On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips
Join us for an interactive discussion with experts who will draw upon recent case studies and provide practical strategies for improving enrolment and retention in clinical trials. This webinar will cover:
• Operational perspectives and practical tips
• Recent applicable regulatory updates and the importance of protocol design
• The principal investigator’s perspective
• Data mining and other creative ways of finding patients.
Host:
• Dr. Lieza Exalto, MD, PhD – neurologist, clinical trialist and researcher, and Scientific Officer (Neurology) at Julius Clinical.
Speakers:
• Prof Rick Grobbee, MD, Phd. Distinguished University Professor, Utrecht University, Founder and Chief Scientific Officer, Julius Clinical.
• Larah de Groot, Project Director at Julius Clinical.
Have questions you’d like addressed during the Q&A? Please send them in advance to: lieza.exalto@juliusclinical.com
Watch webinar
"*" indicates required fields
Related webinars
Webinar – The role of EEG in dementia trials
On May 6th, 2025, we will organised the webinar: The role of EEG in dementia trials During this webinar, our speakers Pieter van Mierlo, Dr. Willem de Haan and host Lieza Exalto will explore the following topics:Practical aspects and resti...
Webinar – Time to event trial designs in ALS: How useful are they?
On NOVEMBER 26th, 2024, we organised the webinar: Time to event trial designs in ALS: How useful are they? During this webinar, our speakers Ruben van Eijk, Lotte Smets, Jordi van Unnik and host Lieza Exalto explored the following topics:A...
Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: 'Clinical Consequences of the New MASLD Nomenclature' with guest speaker Prof. Maja Thiele.During this webinar, our speaker and hosts dived into the following topics:Is the MASLD nomeclature...
